Menu
Symptoms

Hodgkin’s Lymphoma Symptoms

There are no screening tests or early detection tests to find Hodgkin's lymphoma early, however, there are several potential symptoms that could alert a person to the possible presence of Hodgkin's.

Keep in mind when considering the following list of symptoms that: Many are non-specific (they can mean many things other than Hodgkin's), and that some people do not show any symptoms.

 

*The best thing any person can do is bring any concerns they have immediately to their physician or health care professional.

Symptoms

Swollen lymph nodes

  • Painless, swollen nodes in the neck, groin, or clavicle that are hard or rubbery to the touch

    • Cough

  • An unexplained cough, generally coupled with fatigue

    • Nodal pain

  • A rare symptom and one that cannot currently be explained
  • A feeling of pain or discomfort in the lymph nodes upon consuming alcohol

    • Night sweats

  • Drenching night sweats that require changing the sheets

    • Weight loss

  • Unexplained weight loss occurring over several months

    • Fatigue

  • Unexplained, extended fatigue that isn't relieved by getting a good night's rest

    • Fever/Chills

  • Unexplained fever or chills lasting several months

    • Pruritus

  • Skin that is itchy for no obvious or particular reason

    • B Symptoms

    The last five Hodgkin’s lymphoma symptoms listed are considered 'B' symptoms in and tend to signify a less optimistic prognosis than when they are not present.

    Sources

    Lymphomainfo.net
    American Cancer Society
    National Cancer Institute

    More Articles

    More Articles

    Research and Education
    In Association with Amazon.com

    Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

    Leukemia
    What is Myelodysplastic Syndrome?

    The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

    Leukemia
    Merkel Cell Carcinoma and Lymphoma

    Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

    Radiotherapy
    Lymphoma Therapy: Radiotherapy

    Radiation Therapy Topics

    ...
    Lymphoma
    Site Map

    Title /
    Home Page - Where to Start    ...
    Treatment
    Will Cell Therapeutics Ever Go Away?

    At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

    Search Page
    Site Information

    Site Beginnings

    This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

    B-Cell
    Three Papers Look at Efficacy of Idelalisib in CLL, iNHL and MCL

    Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

    Research and Education
    Another Breakthrough Designation Added to Ibrutinib

    The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

    Leukemia
    FDA Expands Imbruvica Label to Include Chronic Lymphocytic Leukemia

    The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

    Research and Education
    FDA Gives Ibrutinib New 'Breakthrough Therapy Designation'

    The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

    Monoclonal Antibodies
    Monoclonal Antibody Kills Chronic Lymphocytic Leukemia Cells

    According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

    Non-hodgkins Lymphoma
    Pharmacyclics Submits NDA for ibrutinib Against MCL and SLL

    Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

    Immunotherapy
    Radioimmunotherapy as Front-Line Treatment for Follicular Lymphoma

    New research suggests that frontline radioimmunotherapy...

    Research and Education
    ASH 2013: Idelalisib Shows Strong Response in Indolent Lymphoma

    Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

    Sitemap